Chulalongkorn University researchers develop AI to assess stroke riskA research team from the Medicine and Engineering faculties of Chulalongkorn University in Thailand has come up with an AI-powered web app to assess patients’ risk…
Continue Reading
Top News
VA Deputy Secretary Donald Remy, JD, who oversees the VA’s Oracle Cerner implementation and other initiatives as its equivalent to COO, resigns as of April 1.
Remy’s departure follows that of VA EHR…
By Anuja Vaidya March 02, 2023 – The adoption of remote patient monitoring (RPM) has skyrocketed, with RPM claim volume increasing by 1,294 percent from January 2019 to November 2022, according to…
Continue Reading
By Mark Melchionna
March 02, 2023 – Recent research from Rutgers, the State University of New Jersey, described how artificial intelligence (AI) and machine learning (ML) could be used to examine genes within DNA,…
Abridge, a company that sells AI software for medical documentation, on Thursday announced the largest deployment of its technology to date. The University of Kansas Health System will adopt the software for more than…
Continue Reading
By Sarai Rodriguez March 02, 2023 – Black women of childbearing age face a twofold risk of uncontrolled high blood pressure compared to their white counterparts, which not only fuels racial health…
Continue Reading
More and more healthcare leaders are beginning to treat violence as a public health issue as gun deaths and other forms of assault continue to impact communities across the country. One large health system…
Continue Reading
Researchers at MIT have developed soft robotic heart replicas that closely match the anatomy of real people. The researchers used medical images of patient hearts to construct computer models that are suitable for 3D…
Continue Reading
What You Should Know:– Lucem Health™ today announced the availability of its new early AI-driven disease detection solutions, Lucem Health Reveal that leverages existing EHR data to identify patients who may be at a…
Continue Reading
Friedrich’s ataxia, an ultra-rare disease that causes progressively worsening muscle function that ultimately leads to death, now has its first FDA-approved therapy. The regulator has given the green light to a Reata Pharmaceuticals drug…
Continue Reading
